Stewart EA

No ORCID on file · 45 papers in corpus · active 1992-2026

Study types

  • article 8
  • other 5
  • review 3
  • letter 1
  • rct 1

Condition tags

  • adenomyosis 9
  • endometriosis 8
  • infertility 4
  • dysmenorrhea 3
2026
American journal of obstetrics and gynecology ·doi:10.1016/j.ajog.2025.12.068

Uterine fibroids (leiomyomas or myomas) are a major issue for individuals with a uterus as well as a disease with profound disparities for Black/African American (Black) individuals. These disparities have roots in early gynecologic practic…

2026
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000002809

OBJECTIVES: To analyze the association between primary infertility and infertility type with the age of natural menopause. METHODS: This is a retrospective cohort study reviewing a subset of women from the Mayo Primary Infertility Cohort (…

other 2026
Menopause (New York, N.Y.) ·doi:10.1097/GME.0000000000002681

OBJECTIVES: To determine the risk of developing de novo carpal tunnel syndrome (CTS), arthritis, or rheumatoid arthritis in women who underwent hysterectomy with bilateral ovarian conservation (H-OC) before reaching spontaneous menopause. …

other 2025
Communications medicine ·doi:10.1038/s43856-025-00961-0

BACKGROUND: The impact of early-life traumatic experiences on late-life morbidity, or chronic conditions, remains unclear. We tested the hypothesis that traumatic adverse childhood experiences, such as physical, verbal, emotional, or sexual…

rct 2025
Fertility and sterility ·doi:10.1016/j.fertnstert.2025.04.037

OBJECTIVE: To assess the effects of relugolix combination therapy in women with uterine fibroids (UFs) and concomitant ultrasound-diagnosed adenomyosis. DESIGN: This post hoc analysis used pooled data from completers of the pivotal LIBERTY…

2024
F&S reports ·doi:10.1016/j.xfre.2024.06.002

ObjectiveTo investigate the efficacy of elagolix plus add-back therapy (estradiol [1 mg] and norethindrone acetate [0.5 mg] once daily) on patient-reported nonbleeding symptoms and menstrual bleeding associated with uterine fibroids (UFs) a…

article 2024
F&S science ·doi:10.1016/j.xfss.2024.06.006

Recognizing the limited information, vague diagnostic criterion, and difficult clinical challenges posed by adenomyosis, the Society of Endometriosis and Uterine Disorders organized an expert symposium to present the current understanding o…

2023
Journal of women's health (2002) ·doi:10.1089/jwh.2022.0133

Objective: To compare 12-month post-treatment health-related quality of life (HR-QoL) and symptom severity (SS) changes among patients with symptomatic uterine fibroids (SUF) not seeking fertility and undergo a hysterectomy, abdominal myome…

article 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1026168

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of th…

other 2023
Maturitas ·doi:10.1016/j.maturitas.2023.01.012

OBJECTIVE: There is limited information on the prevalence of premature and early menopause. Therefore, we studied the frequency and type of premature (age < 40 years) or early (age 40-44 years) menopause in a geographically-defined American…

article 2023
Journal of women's health (2002) ·doi:10.1089/jwh.2022.0207

Background: Hysterectomy, oophorectomy, and tubal ligation are common surgical procedures. The literature regarding cardiovascular disease (CVD) risk after these surgeries has focused on oophorectomy with limited research on hysterectomy or…

review 2023
Current opinion in obstetrics & gynecology ·doi:10.1097/GCO.0000000000000880

PURPOSE OF REVIEW: Uterine fibroids is a common problem in reproductive-age individuals, frequently causing abnormal uterine bleeding, bulk symptoms, and adverse reproductive outcomes. Traditionally, almost half of the women with symptomati…

2022
Journal of women's health (2002) ·doi:10.1089/jwh.2020.8915

Background: Quality of life (QOL) and psychological health has been reported to be decreased among women with gynecological conditions such as uterine fibroids (UFs). Materials and Methods: Women enrolled in the Comparing Options for Manage…

2022
Reproductive health ·doi:10.1186/s12978-021-01313-6

BackgroundThere is growing interest in long-term outcomes following infertility and infertility treatment. However, there are few detailed longitudinal cohorts available for this work. This study aimed to assemble a historical cohort of wom…

2022
Obstetrics and gynecology ·doi:10.1097/aog.0000000000004988

ObjectiveIn the LIBERTY 1 and LIBERTY 2 placebo-controlled trials, once-daily relugolix combination therapy reduced menstrual blood loss volume and pain in women with heavy menstrual bleeding associated with uterine leiomyomas and was well …

2022
Obstetrics and gynecology ·doi:10.1097/aog.0000000000004728

ObjectiveTo evaluate trends in the incidence of premenopausal unilateral and bilateral oophorectomy between 1950 and 2018.MethodsThe Rochester Epidemiology Project medical records-linkage system was used to identify all women aged 18-49 yea…

other 2022
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000004916

OBJECTIVE: To evaluate the association of primary infertility with subsequent bilateral oophorectomy and hysterectomy, using a population-based cohort of women with primary infertility and age-matched women in a referent group. METHODS: Th…

article 2021
F&S reports ·doi:10.1016/j.xfre.2021.05.004

OBJECTIVE: To determine if coexisting adenomyosis limits the efficacy of elagolix, an oral gonadotropin-releasing hormone antagonist, with hormonal add-back therapy in reducing heavy menstrual bleeding in women with uterine fibroids. DESIGN…

2021
Mayo Clinic proceedings ·doi:10.1016/j.mayocp.2020.05.012
2021
Climacteric : the journal of the International Menopause Society ·doi:10.1080/13697137.2021.1893686

In this invited review, we discuss some unresolved and controversial issues concerning premature (<40 years) or early (40-45 years) bilateral oophorectomy. First, we clarify the terminology. Second, we summarize the long-term harmful conseq…

2021
Menopause (New York, N.Y.) ·doi:10.1097/gme.0000000000001804

ObjectiveThe incidence of carpal tunnel syndrome (CTS) is higher in women, and peaks around the age of menopause. Therefore, we investigated whether bilateral oophorectomy is associated with an increased risk of severe CTS.MethodsWe include…

2021
F&S science ·doi:10.1016/j.xfss.2020.11.001

Scientists from multiple basic disciplines and an international group of physician-scientists from the field of obstetrics and gynecology presented recent studies and discussed new and evolving theories of uterine fibroid etiology, growth a…

review 2020
Seminars in reproductive medicine ·doi:10.1055/s-0040-1719016

There is no approved medical therapy for adenomyosis and limited evidence to guide treatments in part due to the complexity of nonhistologic diagnosis and the prevalence of concomitant gynecologic conditions. Most available evidence focuses…

review 2020
Seminars in reproductive medicine ·doi:10.1055/s-0040-1721503

Adenomyosis is a poorly understood and clinically underappreciated gynecologic disorder associated with substantial morbidity including dysmenorrhea, pelvic pain, heavy menstrual bleeding, infertility, and poor pregnancy outcomes. Substanti…

article 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.040

ObjectiveVaginal bromocriptine significantly reduces heavy menstrual bleeding and pain in women with diffuse adenomyosis. The aim of this pilot study was to evaluate whether imaging findings of adenomyosis, as assessed by transvaginal ultra…